Diapositivas sobre el antenimiento de la atención del VIH durante la pandemia de COVID-19 en México

Diapositivas de expertos-autores sobre la colisión de VIH y COVID-19 en México, incluyendo, el impacto del VIH en la prevalencia y la gravedad de la enfermedad de COVID-19, el impacto de la COVID-19 en la atención al VIH en México, y las estrategias e intervenciones para mitigar el impacto de la COVID-19 en la atención del VIH.
Luis E. Soto-Ramirez, MD
Program Director
person default
Luis G. García Demuner, MD
Samuel Navarro, MD
Leticia M. Pérez Saleme, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.81 MB
Released: December 10, 2020

Acknowledgements

Este programa cuenta con una subvención educativa de
ViiV Healthcare

Related Content

Clinical Care Options (CCO) expert analysis of new HIV data from IDWeek 2021, provided by expert HIV faculty

Eric S. Daar, MD Released: October 21, 2021

Slides from CCO: ART in Pregnancy: guideline recommendations and supporting data, pharmacokinetic considerations, and drug-drug interactions

person default Milena Murray, PharmD, MSc, BCIDP, AAHIVP Jonah Musa, MBBS, MSCI, PhD Released: October 20, 2021

Expert selections of important HIV data from IDWeek 2021, including current and investigational ART, HIV PrEP, and metabolic outcomes of ART.

Eric S. Daar, MD Darcy Wooten, MD Released: October 19, 2021

Concise Clinical Care Options (CCO) presentation by Nicholas Chamberlain, MD, on investigational HIV PrEP strategies in various stages of development

Nicholas Chamberlain, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Released: October 15, 2021 Expired: October 14, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue